Abstract:Microneedles have garnered considerable attention over the years as a versatile pharmaceutical platform that could be leveraged to deliver drugs into and across the skin. In the current work, poly (N-isopropylacrylamide) (PNIPAm) is synthesized and characterized as a novel material for the development of a physiologically responsive microneedle-based drug delivery system. Typically, this polymer transitions reversibly between a swell state at lower temperatures and a more hydrophobic state at higher temperatures, enabling precise drug release. This study demonstrates that dissolving microneedles patches made from PNIPAm, incorporating BIS-PNIPAm, a crosslinked polymer variant, exhibit enhanced mechanical properties, evident from a smaller height reduction in microneedle (∼10%). Although microneedles using PNIPAm alone were achievable, it displayed poor mechanical strength, requiring the inclusion of additional polymeric excipients like PVA to enhance mechanical properties. In addition, the incorporation of a thermoresponsive polymer did not have a significant (p> 0.05) impact on the insertion properties of the needles as all formulations inserted to a similar depth of 500 μm into ex vivo skin. Furthering this, the needles were loaded with a model payload, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate (DID) and the deposition of the cargo was monitored via multiphoton microscopy that showed that a deposit is formed at a depth of ≈200 μm. Also, it was revealed that crosslinked-PNIPAm (Bis-PNIPAm) formulations exhibited notable skin accumulationof the dye only after 4 hours, independent of the excipient matrix used. This phenomenon was absent in non-crosslinked PNIPAm formulations, indicating a deposit formation in Bis-PNIPAm microneedle formulation. Collectively, this proof-of-concept study has advanced our understanding on the possibility to use PNIPAm for dissolving microneedle fabrication which could be harnessed for the deposition of nanoparticles into the dermis, for extended drug release within the skin.

Intradermal Implantable PLGA Microneedles for Etonogestrel Sustained Release

Engineered PLGA-PVP/VA based formulations to produce electro-drawn fast biodegradable microneedles for labile biomolecule delivery

Preparation and In Vitro Characterization of Microneedles Containing Inclusion Complexes Loaded with Progesterone

Preparation and characterization of 3D printed PLA microneedle arrays for prolonged transdermal drug delivery of estradiol valerate

Fabrication of controlled-release polymeric microneedles containing progesterone-loaded self-microemulsions for transdermal delivery

Design, optimization, and evaluation for a long-time-released transdermal microneedle delivery system containing estradiol

Long-acting microneedles: a progress report of the state-of-the-art techniques

Biodegradable Gelatin Methacryloyl Microneedles for Transdermal Drug Delivery

Hydrogel Microneedles with Programmed Mesophase Transitions for Controlled Drug Delivery

Exploring Trehalose on the Release of Levonorgestrel from Implantable PLGA Microneedles

PEGDA/PVP Microneedles with Tailorable Matrix Constitutions for Controllable Transdermal Drug Delivery

Two Photon Polymerization-Micromolding of Polyethylene Glycol-Gentamicin Sulfate Microneedles

Transdermal Delivery of Therapeutics Through Dissolvable Gelatin/sucrose Films Coated on PEGDA Microneedle Arrays with Improved Skin Permeability

A bilayer microneedle for therapeutic peptide delivery towards the treatment of diabetes in db/db mice

Leveraging novel innovative thermoresponsive polymers in microneedles for targeted intradermal deposition

Sustained estradiol valerate delivery by microneedles: A new effective platform to construct estrogen-dependent tumor model

Fabrication of Rapidly Separable Microneedles for Transdermal Delivery of Metformin on Diabetic Rats

Polymeric Microneedle-Mediated Sustained Release Systems: Design Strategies and Promising Applications for Drug Delivery.

Biodegradable double-network GelMA-ACNM hydrogel microneedles for transdermal drug delivery

Fabrication of Poly Lactic- co-Glycolic Acid Microneedles for Sustained Delivery of Lipophilic Peptide-Carfilzomib

Sugar-Triggered Burst Drug Releasing Poly-Lactic Acid (PLA) Microneedles and Its Fabrication Based on Solvent-Casting Approach